Not an actual patient
®
AstraZenecaPharmaceuticals(Pty)Limited.Reg.No.1992/005854/07.5LeeuwkopRoad,Sunninghill,2157.Tel:(011)797-6000.Fax:(011)797-6001.www.astrazeneca.co.za.® isaregistered trademark.
S3Atacand 8mg
(Tablet).
®
®
Each ATACAND 8 mg tablet contains 8mg candesartan cilexetil. 32/7.1.3/0099.
S3 Atacand 16 mg
(Tablet). Each ATACAND 16 mg tablet contains 16 mg candesartan cilexetil. 32/7.1.3/0100. EPI date: 27/06/2007.
S3 Atacand 32 mg
(Tablet). Each ATACAND 32 mg tablet contains 32 mg candesartan cilexetil. A39/7.1.3/0244. EPI date: 13/12/2007.
INDICATIONS:
ATACAND is indicated for mild to moderate hypertension. It may be used alone or in combination with
other antihypertensive agents such as thiazide diuretics and dihydropyridine calcium antagonists, for enhanced efficacy. Heart Failure:Treatment with ATACAND reduces mortality, reduces hospitalisation due to heart failure, and
improvessymptoms inpatientswith leftventricularsystolicdysfunction(LVEF 40%).For fulldetailsrelating toany informationmentionedabovepleaserefer to thepackage inserts.
CandesartanCilexetil ismanufacturedunder
the license fromTakedaChemicals Industries,Ltd.
Datecompiled:February2011.
